Literature DB >> 20084067

Taming killer cells may halt diabetes progression.

Francesco Colucci1, Corrado M Cilio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20084067     DOI： 10.1038/ni0210-111

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

Review 1.  Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes.

Authors:  Martin J Richer; Marc S Horwitz
Journal:  Autoimmun Rev       Date:  2009-02-11       Impact factor: 9.754

Review 2.  Natural killer cells in human autoimmunity.

Authors:  Malin Flodström-Tullberg; Yenan T Bryceson; Fu-Dong Shi; Petter Höglund; Hans-Gustaf Ljunggren
Journal:  Curr Opin Immunol       Date:  2009-11-04       Impact factor: 7.486

3.  The activating receptor NKp46 is essential for the development of type 1 diabetes.

Authors:  Chamutal Gur; Angel Porgador; Moran Elboim; Roi Gazit; Saar Mizrahi; Noam Stern-Ginossar; Hagit Achdout; Hormas Ghadially; Yuval Dor; Tomer Nir; Victoria Doviner; Oren Hershkovitz; Michal Mendelson; Yaakov Naparstek; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

Review 4.  Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

Authors:  Marco Colonna
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

5.  Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.

Authors:  S G Paik; N Fleischer; S I Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

Authors:  Gili G Halfteck; Moran Elboim; Chamutal Gur; Hagit Achdout; Hormas Ghadially; Ofer Mandelboim
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

7.  NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

Authors:  Tadepally Lakshmikanth; Shannon Burke; Talib Hassan Ali; Silvia Kimpfler; Francesco Ursini; Loredana Ruggeri; Marusca Capanni; Viktor Umansky; Annette Paschen; Antje Sucker; Daniela Pende; Veronika Groh; Roberto Biassoni; Petter Höglund; Masashi Kato; Kazuko Shibuya; Dirk Schadendorf; Andrea Anichini; Soldano Ferrone; Andrea Velardi; Klas Kärre; Akira Shibuya; Ennio Carbone; Francesco Colucci
Journal:  J Clin Invest       Date:  2009-04-06       Impact factor: 14.808

8.  Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?

Authors:  Eric Vivier; Hergen Spits; Tom Cupedo
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

9.  NKG2D blockade prevents autoimmune diabetes in NOD mice.

Authors:  Kouetsu Ogasawara; Jessica A Hamerman; Lauren R Ehrlich; Helene Bour-Jordan; Pere Santamaria; Jeffrey A Bluestone; Lewis L Lanier
Journal:  Immunity       Date:  2004-06       Impact factor: 31.745

Review 10.  Human natural killer cell receptors and co-receptors.

Authors:  R Biassoni; C Cantoni; D Pende; S Sivori; S Parolini; M Vitale; C Bottino; A Moretta
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988
View more
  3 in total

1.  BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection.

Authors:  Bibo Zhu; Ruixuan Zhang; Chaofan Li; Li Jiang; Min Xiang; Zhenqing Ye; Hirohito Kita; Ari M Melnick; Alexander L Dent; Jie Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

Review 2.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

3.  Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.

Authors:  Rami Yossef; Chamutal Gur; Avishai Shemesh; Ofer Guttman; Uzi Hadad; Shlomo Nedvetzki; Antonija Miletić; Karen Nalbandyan; Adelheid Cerwenka; Stipan Jonjic; Ofer Mandelboim; Angel Porgador
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.